Has Cesar Garcia received payments from drug or device companies?

Yes. Drug and device makers reported $8,907 in general payments to Cesar Garcia across 193 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cesar Garcia did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cesar Garcia come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cesar Garcia

Physician Assistant · Pharr, TXNPI 1912534819

Payments from drug & device makers

$8,907in general payments, 2019–2025

Across 193 payments — averaging $46.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$5K
Optinose US, Inc.$1K
Novo Nordisk$526
AstraZeneca$331
Amgen$318
Inspire Medical Systems, Inc.$300
plus $1K from 15 others

What the payments were for

Travel & lodging$3,53040%
Food & beverage$5,21559%
Education$1612%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	40	$4,748
Optinose US, Inc.	34	$1,470
Novo Nordisk	28	$526
AstraZeneca	13	$331
Amgen	16	$318
Inspire Medical Systems, Inc.	5	$300
Regeneron Healthcare Solutions, Inc.	7	$169
AbbVie	8	$159
Lilly USA, LLC	14	$144
Stryker	2	$132
GSK	6	$128
Otsuka America Pharmaceutical, Inc.	5	$105
Phadia US Inc.	2	$91
Dexcom, Inc.	2	$48
Acclarent, Inc	2	$45
Abbott	2	$39
Olympus America Inc.	2	$38
Orthofix Medical, Inc.	1	$35
Astellas Pharma US Inc	2	$34
Boston Scientific	1	$27
Sumitomo Pharma America, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,907 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
FarxigaDapagliflozin Propanediol	40	$40,047
OzempicSemaglutide	11	$13,397
MounjaroTirzepatide	13	$13,317
JardianceEmpagliflozin	12	$13,021
Xigduo XrDapaglifloz Propaned/Metformin	11	$10,654
MyrbetriqMirabegron	19	$8,786
Lagevrio (Eua)Molnupiravir	16	$6,350
Albuterol Sulfate HfaAlbuterol Sulfate	33	$880
Atorvastatin Calcium	68	$703
Ipratropium Bromide	22	$565
FenofibrateFenofibrate Nanocrystallized	14	$559
Ciprofloxacin Hcl	115	$553
Levothyroxine Sodium	40	$462
Dicyclomine Hcl	41	$448
Rosuvastatin Calcium	27	$423

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AstraZenecaFarxiga	$331	$40,04740 claims
Novo NordiskOzempic	$526	$13,39711 claims
Lilly USA, LLCMounjaro	$144	$13,31713 claims
Astellas Pharma US IncMyrbetriq	$34	$8,78619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Pharr

Cynthia TrickettDallas$1.3M
Kristine KuceraMelissa$797K
Selina SantosAustin$543K
Matthew BrunoMcKinney$538K
Anthony DerenciusSan Antonio$507K
Brooke HodnickSouthlake$479K
Holly GloverArlington$418K
Kirk GautierAthens$416K
Jaime RomanPlano$338K
Michael WhiteDallas$276K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →